Abstract
The role of the trace minerals, copper (Cu) and zinc (Zn) are important in maintaining blood pressure. Copper has been found to inhibit the activity of angiotensin’s converting enzyme. An interrelationship has been found to exist between Cu and Zn. Data in renal (RH) and spontaneous hypertensive rates (SHR) regarding Cu and Zn is lacking. The purpose of this report was to measure Cu and Zn levels in two types of experimental animal models of hypertension compared to normotensive (NT) rats. Blood samples were drawn to measure serum levels of Cu and Zn in three types of animals, RH, SHR, and NT. Serum Cu values were found to be lower, whereas Zn levels were elevated in the SHR animals. Serum levels of Cu and Zn in the RH animals were similar to those found in the NT animals. Further study of the interaction of those trace minerals is documented, and extends over knowledge of the role of minerals in blood pressure control.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Y. S. Bakhle and A. M. Reynard,Nature New Biol. 229, 187–189 (1971).
F. E. Dorer, L. T. Skeggs, J. R. Kahn, K. F. Lentz, and M. Levine,Analyst Biochem. 33, 102–113 (1970).
A. Prasad, G. Brewer, E. B. Schoomaker, et al.,JAMA 240, 2166–2168 (1978).
E. Perry, M. Erlanger, and E. Perry,Environ. Health Perspect. 28, 251–260 (1979).
Y. R. Yamour, H. Horie, K. Tanase, Fugiuara, Y. Nara, and W. Lodenberg,Hypertension 6, 49–53 (1984).
M. Friedman and S. Freed,Proc. Soc. Exp. Biol. Med. 70, 670–672 (1949).
A. Grollman,Proc. Soc. Exp. Biol. Med. 57, 102–104 (1944).
R. Peaston,Med. Lab. Tech. 30, 249 (1973).
P. Trinder,Ann. Clin. Biochem. 22, 158–161 (1969).
M. Fields, R. Ferretti, J. Smith, and S. Reiser,Amer. J. Clin. Nutr. 39, 289–295 (1984).
M. Fields, R. Ferretti, J. Smith, and S. Reiser,Life Sci. 34, 763–769 (1984).
Purina mills Animals Diet Reference Guide, St. Louis, 1987, p. 38.
T. Kurtz, M. Montano, L. Chan, and P. Kadra,Hypertension 13 188–192 (1989).
J. R. Goodman, J. B. Wershaw, and P. R. Dallman,Pediatr. Res. 4, 244–256 (1970).
H. F. Loyke,Pharmacol. Res. Commun. 9, 181–186 (1977).
M. A. Pfeffer and E. D. Frohlich,Circ. Res. 32(1), 28–35 (1973).
H. F. Loyke,JEPTO 7, 1–8 (1986).
R. E. Serfass, Kyeung-Ewn Park, and M. L. Koplan,Proc. Soc. Exp. Biol. Med. 189, 229–239 (1988).
H. F. Loyke,Proc. Soc. Exp. Biol. Med. 115, 1035–1140 (1964a).
H. F. Loyke,Proc. Soc. Exp. Biol. Med. 134, 248–251 (1970a).
H. F. Loyke,Environ. Contam. Toxicol. 32, 405–409 (1984).
B. Valley,Advances in Protein Chemistry, M. Anson, K. Bailey, and J. Edsall, eds., Academic, NY, 1955, pp. 317–384.
L. Klevay,Ann. NY Acad. Sci. 355, 140–151 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Loyke, H.F. Copper and zinc in experimental hypertension. Biol Trace Elem Res 29, 45–49 (1991). https://doi.org/10.1007/BF03032673
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03032673